期刊文献+

RNA干扰Bcl-2基因表达对人胆管癌细胞及胆囊癌细胞株裸鼠移植瘤生长的抑制 被引量:3

RNA interference mediated Bcl-2 gene silence inhibits growth of human cholangiocarcinoma and gallbladder carcinoma xenograft in nude mice
在线阅读 下载PDF
导出
摘要 目的:探讨Bcl-2基因的小干扰RNA(siRNA)真核表达载体干扰Bcl-2基因表达对人胆管癌细胞QBC939、胆囊癌细胞GBC-SD裸鼠体内移植瘤生长的抑制作用。方法:分别制作人胆管癌细胞QBC939、胆囊癌细胞GBC-SD细胞株移植瘤模型,随机分为3组,pSilencerTM-EGFP sh515组(实验组)、pSilencerTM-EGFP shCon组(空载体阴性对照组)和对照组。实验组用Bcl-2基因的小干扰RNA(siRNA)真核表达载体多点注射于移植瘤周围,空载体阴性对照组用空载体多点注射于移植瘤周围,对照组不作处理,观察其生长情况,计算肿瘤生长体积、生长率。6周后,处死裸鼠,剥离瘤体组织进行称重,并采用免疫组化检测Bcl-2蛋白的表达。结果:成功建立裸鼠人胆管癌细胞QBC939,胆囊癌GBC-SD细胞的动物模型。胆管癌细胞实验组、空载体阴性对照组、对照组瘤体平均体积(mm3)分别为:801.776±59.6,1383.980±78.2,1490.235±89.0。瘤体平均瘤体重量(g)为:0.90±0.11,1.49±0.31,1.63±0.22。平均生长率为:20.558%,35.587%,38.211%。人胆囊癌细胞实验组、空载体阴性对照组、对照组瘤体平均体积(mm3)分别为:729.736±66.6,1493.162±98.9,1548.668±101.0。瘤体平均瘤体重量(g)为:0.82±0.10,1.68±0.21,1.90±0.25。平均生长率为:18.711%,38.286%,39.709%。两组实验组分别和空载体阴性对照组、对照组比较有统计学意义(P<0.05),空载体阴性对照组和对照组比较无统计学意义(P>0.05)。结论:针对Bcl-2基因siRNA真核表达载体通过局部多点注射于移植瘤周围可以有效降低Bcl-2基因的表达,该基因沉默后肿瘤细胞增殖受到抑制,体内瘤体生长减慢。 Objective:Investigating RNA interference mediated Bcl-2 gene silence can inhibit growth of the cholangiocarcinoma and gallbladder carcinoma xenograft in nude mice.Methods: The animal models of human cholangiocarcinoma and Gallbladder carcinoma in nude mice body were set up.The nude mice were randomly divided into three groups: pSilencerTM-EGFP sh515,pSilencerTM-EGFP shCon,control group.After the formation of tumor knot,siRNA expressing plasmids pSilencerTM-EGFP sh515 and pSilencerTM-EGFP shCon were injected into the knots of pSilencerTM-EGFP sh515 group and pSilencerTM-EGFP shCon group.The volumes of the tumors were measured and the tumor growth rates were calculated.All mice were sacrificed after 6 weeks.The distribution of Bcl-2 in the tumors was detected by immunohistochemistry.Results: The nude mouse model of human cholangiocarcinoma and gallbladder cancer xenograft tumor was constructed successfully.The cholangiocarcinoma average tumor volumes(mm3)in pSilencerTM-EGFP sh515 group,pSilencerTM-EGFP shCon group,control group was 801.776±59.6,1383.980±78.2,1490.235±89.0,and the average tumor weight(g) was 0.90±0.11,1.49±0.31,1.63±0.22,and the average growth rates was 20.558%,35.587%,38.211%.The gallbladder cancer average tumor volumes(mm3)in pSilencerTM-EGFP sh515 group,pSilencerTM-EGFP shCon group,control group were 729.736±66.6,1493.162±98.9,1548.668±101.0,and the average tumor weight(g) was 0.82±0.10,1.68±0.21,1.90±0.25,and the average growth rates were 18.711%,38.286%,39.709%.The average tumor volume,weight and growth rates of pSilencerTM-EGFP sh515 group was significantly smaller than that of pSilencerTM-EGFP shCon group and control group(P0.05),and there was no significant difference between pSilencerTM-EGFP shCon group and control group(P0.05).Conclusion: By local injection,siRNA vector can effectively degrade the expressive level of Bcl-2 gene.After silence of Bcl-2 gene,the xenograft growth rate decreased.
机构地区 陕西省肿瘤医院
出处 《现代肿瘤医学》 CAS 2012年第1期31-34,共4页 Journal of Modern Oncology
基金 陕西省自然科学基金资助项目(No.2003C2 47)
关键词 胆管癌 胆囊癌 BCL-2基因 RNA干扰 移植瘤 基因治疗 gallbladder carcinoma Bcl-2 gene RNA interference xenograft gene therapy
  • 相关文献

参考文献4

二级参考文献22

共引文献23

同被引文献36

  • 1刘珣,王海连.CEA、CA19-9、CA50、CA125监测在胆囊癌早期诊断和预后判断中的应用[J].中国误诊学杂志,2009,9(3):577-578. 被引量:14
  • 2高峻,韩殿冰,张朝.胆囊癌临床研究进展[J].河南外科学杂志,2010,16(2):88-89. 被引量:15
  • 3石景森,孙学军.原发性胆囊癌诊治的历史、现状及展望[J].西安交通大学学报(医学版),2007,28(5):473-477. 被引量:38
  • 4Samuelsson B,Morgenstern R,Jakobsson PJ. Membrane prostaglandin E synthase-1:a novel therapeutic target[J].Pharmacological Reviews,2007,(03):207-224.
  • 5Takii Y,Abiru S,Fujioka H. Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma[J].Liver International,2007,(07):989-996.
  • 6Kamei D,Murakami M,Nakatani Y. Potential role of microsomal prostaglandin E synthase-1 in turnorigenesis[J].Journal of Biological Chemistry,2003,(21):19396-19405.
  • 7Sampey AV,Monrad S,Crofford LJ. Microsomal prostaglandin E synthase-1:the inducible synthase for prostaglandin E2[J].Arthritis Research &#x0026; Therapy,2005,(03):114-117.
  • 8Mayoral R,F-martinez A,Bosca L. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells[J].Carcinogenesis,2005,(04):753-761.doi:10.1093/carcin/bgi022.
  • 9Wang HW,Hsueh CT,Lin CF. Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non small-cell lung cancer[J].Annals of Surgical Oncology,2006,(09):1224-1234.doi:10.1245/s10434-006-9001-4.
  • 10Muller-decker K,Furstenberger G. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis[J].Molecular Carcinogenesis,2007,(08):705-710.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部